Scorpius Inc. (SCPX)
AMEX: SCPX
· Real-Time Price · USD
0.04
-0.01 (-12.47%)
At close: May 01, 2025, 2:15 PM
0.04
0.00%
After-hours: May 01, 2025, 02:15 PM EDT
-12.47% (1D)
| Bid | 0.04 |
| Market Cap | 249.02K |
| Revenue (ttm) | 10.04M |
| Net Income (ttm) | -28.81M |
| EPS (ttm) | -1901.49 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.05 |
| Volume | 109,310 |
| Avg. Volume (20D) | 833,640 |
| Open | 0.05 |
| Previous Close | 0.05 |
| Day's Range | 0.04 - 0.05 |
| 52-Week Range | 0.03 - 800.00 |
| Beta | 0.88 |
About SCPX
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 24, 2013
Employees 82
Stock Exchange AMEX
Ticker Symbol SCPX
1 week ago
-42.86%
SCORPIUS Holdings shares are trading lower after t...
Unlock content with
Pro Subscription
3 months ago
+3.29%
Scorpius Holdings shares are trading lower after the company announced its board approved a 1-for-20 reverse stock split.
10 months ago · businesswire.com
NYSE American to Commence Delisting Proceedings Against Scorpius Holdings, Inc. (SCPX)NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of ...